ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,651Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 783

$1.13M Total Retail Price of All Prescriptions

Rank: 33 out of 783

587 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 587 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 587 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 11,685 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 574 413 1 1
OMEPRAZOLE 518 381 2 6
SIMVASTATIN 456 377 3 3
LISINOPRIL 399 336 4 4
HYDROCODONE-ACETAMINOPHEN 358 238 S3 5 2
AMLODIPINE BESYLATE 350 321 6 5
FUROSEMIDE 333 295 7 7
PRAVASTATIN SODIUM 319 236 8 14
METOPROLOL TARTRATE 259 230 9 9
WARFARIN SODIUM 246 233 10 10
CITALOPRAM HBR 235 168 11 19
ATORVASTATIN CALCIUM 216 180 12 11
ALLOPURINOL 213 198 13 31
TRAMADOL HCL 206 120 14 20
HYDROCHLOROTHIAZIDE 195 186 15 12
METOPROLOL SUCCINATE 183 151 16 13
MELOXICAM 171 137 17 37
ATENOLOL 170 152 18 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 168 145 19 33
METFORMIN HCL ER 162 140 20 64
DONEPEZIL HCL 162 160 20 24
POLYETHYLENE GLYCOL 3350 158 83 22 43
PANTOPRAZOLE SODIUM 155 92 23 30
ZOLPIDEM TARTRATE 153 123 24 23
CARVEDILOL 150 119 25 21
ALENDRONATE SODIUM 148 123 26 25
RANITIDINE HCL 144 84 27 44
LOSARTAN POTASSIUM 137 124 28 18
CLOPIDOGREL 134 116 29 29
TRAZODONE HCL 130 92 30 39
TAMSULOSIN HCL 127 92 31 26
NEXIUM 126 110 32 28
CYMBALTA 121 78 33 35
BUPROPION XL 110 41 34 172
LOSARTAN-HYDROCHLOROTHIAZIDE 106 86 35 53
LOVASTATIN 106 81 35 58
GABAPENTIN 106 74 35 15
FAMOTIDINE 105 69 38 55
AMITRIPTYLINE HCL 105 71 R 38 77
ISOSORBIDE MONONITRATE ER 102 98 40 40
KLOR-CON M20 102 56 40 48
TRIAMTERENE-HCTZ 100 76 42 42
SERTRALINE HCL 100 70 42 22
PREDNISONE 92 70 44 36
CRESTOR 91 62 45 27
PLAVIX 91 80 45 51
METFORMIN HCL 87 62 47 8
FLUTICASONE PROPIONATE 85 63 48 46
ESCITALOPRAM OXALATE 83 66 49 54
FINASTERIDE 83 58 49 127
DIOVAN HCT 83 67 49 94
GLIMEPIRIDE 81 79 52 34
LEVETIRACETAM 80 31 53 89
LANTUS 77 68 54 38
DOXYCYCLINE HYCLATE 77 41 54 112
JANUVIA 74 53 56 73
LIPITOR 72 36 57 114
OXYBUTYNIN CHLORIDE ER 72 60 57 117
OXYBUTYNIN CHLORIDE 72 59 57 96
CLONIDINE HCL 66 29 60 60
FLUOXETINE HCL 66 44 60 45
CYCLOBENZAPRINE HCL 66 23 R 60 63
SPIRONOLACTONE 66 50 60 57
VESICARE 66 53 60 188
ADVAIR DISKUS 65 49 65 50
PROAIR HFA 64 46 66 56
POTASSIUM CHLORIDE 64 48 66 16
INSULIN SYRINGE 64 46 66 82
SYNTHROID 62 40 69 47
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 38 69 95
PEN NEEDLE 60 48 71 103
NAMENDA 60 60 71 32
PAROXETINE HCL 57 31 73 69
ACTONEL 55 39 74 224
ALPRAZOLAM 53 41 75 145
RISPERIDONE 53 19 75 67
PROPRANOLOL HCL 52 31 77 129
LEVOXYL 51 47 78 150
CELEBREX 50 33 79 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.